Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab

We report a case of tumefactive demyelination (TD) in an ocrelizumab-treated patient with RRMS.

Source: Neurology Neuroimmunology and Neuroinflammation - June 25, 2019 Category: Neurology Authors: Moreira Ferreira, V. F., Meredith, D., Stankiewicz, J. M. Tags: Clinical neurology history, Multiple sclerosis Clinical/Scientific Notes Source Type: research